
HCG’s West Asia patient volumes drop 60-70%, opening 90-day UAE referral window
HealthCare Global Enterprises reported a 60-70% fall in West Asian patient volumes, giving UAE hospitals a short window to capture delayed oncology, cardiac and orthopaedic referrals.
How Zavis verifies this coverage
Editorial standards, source rules, methodology, and review provenance are public.
HealthCare Global Enterprises reported a 60-70% drop in West Asian patient volumes between March and May 2026, creating a 90-day referral window for UAE hospitals with spare complex-care capacity.
For healthcare executives, the operating question is immediate: can UAE hospitals convert delayed India-bound cases before flight capacity, insurer approvals and embassy referral flows return to normal in June and July 2026?
India’s referral pipeline has stalled
The disruption was reported after Travel And Tour World cited a medical-tourism freeze involving Iran, Saudi Arabia, Yemen, Oman, Iraq and the UAE. Separate coverage by Business Standard said listed Indian hospital companies still grew medical value tourism revenue in FY26, while international patient volumes fell because of disruptions tied to West Asia and Bangladesh.
The Economic Times, citing The Times of India on 25 May 2026, reported that HCG saw a 60-70% year-on-year fall in West Asian patient volumes. Max Healthcare also reported weaker arrivals from Iraq, Oman, Yemen, Saudi Arabia and the UAE. The affected specialties are high-yield cross-border categories: oncology, transplants, cardiac surgery and orthopaedics.
- HCG: West Asian patient volumes down 60-70% year on year between March and May 2026.
- Max Healthcare: lower arrivals from at least 5 West Asian source markets.
- India: foreign medical arrivals were about 644,387 in 2024, according to tourism data cited by Mint.
- Middle East: about 18% of India’s foreign medical arrivals in 2024, according to Economic Times coverage of tourism ministry data.
UAE providers can compete beyond wellness
The UAE already has a measurable health-tourism base. Dubai Health Authority (DHA) reported 674,000 medical tourists in 2022, with spending of AED 992 million. DHA figures reported for 2023 put Dubai at 691,000 medical tourists and more than AED 1.03 billion in health spending.
Regulatory execution will decide how much of the delayed demand UAE providers can keep. DHA covers Dubai; the Department of Health - Abu Dhabi (DOH) covers Abu Dhabi and Al Ain; the Ministry of Health and Prevention (MOHAP) covers Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah. International-patient growth will test consent documentation, package pricing, discharge summaries, data transfer and post-treatment follow-up across more than 3 regulatory channels.
Cleveland Clinic Abu Dhabi reported 35% growth in international patient volume for 2024, with demand led by cardiology, ophthalmology, neurology and urology. Its top source countries included Kuwait, Saudi Arabia, Pakistan, Bahrain and the USA. Those data points give Abu Dhabi a credible base for complex-care referrals if hospitals publish clear package prices and outcome data.
Move before routes reopen
Hospital CEOs should treat the next 90 days as a business-development window. The target is narrow: patients from Iraq, Oman, Yemen, Saudi Arabia and the UAE who deferred India-based treatment after airspace disruption, flight suspensions or insurance delays. Marketing teams should replace broad wellness campaigns with Arabic-language pathways for 4 service lines: oncology second opinions, cardiac surgery, joint replacement and transplant follow-up.
COOs should audit international-patient workflows before campaigns expand. The likely bottlenecks are airport transfer, medical record translation, teleconsultation triage, ICU availability, payer pre-authorisation and family accommodation. A provider that cannot issue a bundled estimate within 48 hours will lose patients to Turkey, Thailand or a reopened India corridor.
The commercial risk is timing. Indian chains are diversifying into Africa, Central Asia and Southeast Asia, according to Economic Times coverage from 9 March 2026. UAE providers should track June and July 2026 flight capacity, insurer approvals and embassy referral patterns before adding permanent headcount. The P&L case is strongest for hospitals that already have DHA, DOH or MOHAP-compliant international desks and spare high-acuity capacity.
Intelligence Desk
Editorial
Contributing to UAE healthcare industry coverage
Related coverage
FAQ
What is the current state of UAE healthcare investment?
HealthCare Global Enterprises reported a 60-70% fall in West Asian patient volumes, giving UAE hospitals a short window to capture delayed oncology, cardiac and orthopaedic referrals. Follow Zavis Healthcare Industry Insights for ongoing financial coverage of the healthcare sector.



